UNRESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for UNRESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug enters first human testing
Disease control Recruiting nowThis is the first human study of a new chemotherapy drug called TR-002. It aims to find the safest dose and understand side effects for people with advanced solid tumors, including pancreatic cancer, that have stopped responding to standard treatments. The study will enroll 52 pa…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough pancreatic cancers: can adding a targeted drug help patients live longer?
Disease control Recruiting nowThis study is for people with advanced pancreatic cancer that has stopped responding to their first treatment. It is testing if adding a targeted drug called panitumumab to standard second-line chemotherapy helps patients live longer than chemotherapy alone. The trial is specific…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Light therapy trial aims to boost immune attack on pancreatic cancer
Disease control Recruiting nowThis study is testing a new combination treatment for pancreatic cancer that cannot be removed by surgery or has spread. The approach uses a light-activated drug injected into the tumor to help the patient's own immune system, boosted by an immunotherapy drug (pembrolizumab), bet…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists hunt for hidden types of cancer wasting
Knowledge-focused Recruiting nowThis study aims to better understand cancer cachexia, the severe weight and muscle loss that often occurs with advanced cancers. Researchers will observe 800 patients with advanced colorectal, lung, or pancreatic cancer to identify different patterns or 'subtypes' of this conditi…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC